Embed Size (px)
Citation preview
DAY 2 Friday, March 6, 202021:3020:0019:0018:0017:0016:0015:0014:0013:0012:0011:0010:009:008:007:30
Glass Building
Hall EHall Building
Tokyo International Forum
Room14FHall C
Room27F
Hall B7（1）
Room37F
Hall B7（2）
Room45F
Hall B5
Room57F
Hall D7
Room65F
Hall D5
Room71F
Hall D1
Room85FG502
Room95FG510
Room104FG402
Room114FG409
Room126FG602
PosterB2F
ExhibitionB2F
: English EL : Educational LectureLS : Luncheon Seminar SS : Sweets SeminarE
17:15～18:008:30～10:00
9:00～18:00
10:00～17:15
9:00～10:00 10:10～11:10
9:00～10:00 10:10～11:10
9:00～10:00 10:10～11:10
9:00～10:00 10:10～11:10
10:10～10:58
10:20～11:08
9:00～10:00
9:00～9:48
9:00～10:12
10:10～11:22
13:25～14:37
13:30～14:30 14:40～15:40
13:30～14:30 14:40～15:40
13:30～14:30 14:40～15:28
14:50～15:50
13:30～14:42 14:50～16:02
13:30～14:42
13:30～14:42
9:00～10:00 13:45～14:4510:10～11:10
13:50～14:30 14:40～15:55
14:40～15:55
Reception19:30～21:30
9:00～11:00 13:45～15:15
9:00～10:30
9:00～10:30
13:30～14:40 14:45～16:0010:40～11:10
18:30～13:00～13:45
11:30～12:20 16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
12:35～13:00
9:00～9:30 9:35～10:05 10:10～10:40 10:45～11:15 13:30～14:00 14:05～14:35 14:40～15:10 15:15～15:45
MiniConcert
14:55～15:55
18:00～18:30
14:50～16:02
Oral Session 1Transplant Source 1Yasuyuki Arai
Oral Session 2Transplant Source 2Yoshihiro Inamoto
Oral Session 16Viral Infection 1Takanobu Morishita
Oral Session 17Viral Infection 2Akihiro Yokoyama
Oral Session 20LTFU/QOLYasuyuki Inoue
Oral Session 21ImmunizationSatoshi Iyama
Oral Session 24Rehabilitation 1
Eisei Kondo
Oral Session 25Rehabilitation 2Hiroya Tamaki
Oral Session 9GVHD/GVL 2Kazutaka Ozeki
Oral Session 13Early Complication(Engraftment Failure)Satoshi Nishiwaki
Oral Session 4Conditioning 1Naomi Kawashima
Oral Session 8GVHD/GVL 1Hiroaki Shimizu
Oral Session 12Early Complication(TMA/SOS)Takahiko Nakane
Oral Session 5Conditioning 2Shigeru Kusumoto
Oral Session 3Transplant Source 3
Ayako Arai
Oral Session 10GVHD/GVL 3Tomomi Toubai
Oral Session 11GVHD/GVL 4Tatsunori Goto
Oral Session 18Immunotherapy/Cell Therapy 1Kazuhiko Ikeda
Oral Session 19Immunotherapy/Cell Therapy 2Shinichi Kako
Oral Session 22Nutrition
Management 1Shigeo Fuji
Oral Session 23Nutrition
Management 2Sachiko Seo
Oral Session 27Histocompatibility
AntigenIlseung Choi
Oral Session 6Immune ReconstitutionShingo Kurahashi
Oral Session 7TDM/DrugsTakuro Nishikawa
Oral Session 14Early Complication(Pretransplant Evaluation/Others)Hisayuki Yokoyama
Oral Session 26Management/Care/Team Medical-care
Taku Kikuchi
Oral Session 15Early Complication(Heart/Lungs/Central Nervous System)Kentaro Fukushima
Oral Sessionfor Nurse 1
Transplant NursingYumiko Kiso Yuko Shimizu
Oral Sessionfor Nurse 2LTFU/QOLKazuyo YoshikawaRei Yamaoka
The allied organizations forumfor promoting hematopoieticstem cell transplantation
【Live Video】The forum of allied organizationspromoting hematopoietic stemcell transplantation (HSCT)
Symposium 1Recent advances in genomicsand genome-engineering inHematology/OncologyKoichi Akashi, Seishi Ogawa
SpecialPlanning 1Minoko TakahashiShuichi Taniguchi
Nursing EducationalLecture 1
Speaker: Yuka OzasaChair: Kazue Mori
Nursing EducationalLecture 2
Speaker: Sanae TakanashiChair: Megumi Fujisawa
OpeningCeremony
EL1Speaker: Nobuhiro TsukadaChair: Chiaki Nakaseko
EL2Speaker: Tomohiro MorioChair: Yoshiyuki Takahashi
EL3Speaker: Hiroki YamaguchiChair: Fumihiko Ishikawa
EL4Speaker: Gou YamamotoChair: Koji Idutsu
EL5Speaker: Atsushi KikutaChair: Takahiro Fukuda
EL6Speaker: Atsushi ManabeChair: Masami Inoue
EL7Speaker: Hiroshi KimuraChair: Kimikazu Matsumoto
EL8Speaker: Takahiro MaedaChair: Seishi Ogawa
PosterPresentationPoster mounting Poster viewing
Exhibition
E
E
E
Symposium 2Cord Blood Transplantation
in Future Satoshi Takahashi, Shuichi Taniguchi
Current Seminar 1Koji NagafujiTakahiro Fukuda
HCTC WorkshopShinichiro Mori, Yuka Nagai
Workshop 1Yuichiro NawaYoshikiyo Ito
Workshop 2Takehiko MoriYoshihiko Soga
CurrentSeminar 2Akihiro Shimosaka
E
LS1The importance of oral supportive care for
hematopoietic stem cell transplantation recipients - to fulfill our responsibility for life
Speaker: Yoshihiko SogaChair: Maki Yokota
（Chugai Pharmaceutical Co., Ltd）
SS1High-dose chemotherapy in pediatric malignant solid tumorSpeaker: Fuminori Iwasaki Maki Taduke
Chair: Masami Inoue Tomoko Fukuchi
（Sumitomo Dainippon Pharma Co., Ltd.）
SS2Pathophysiology and immune-targeted therapeutic approach of multiple myeloma in 2020Speaker: Junya KurodaChair: Kazutaka Sunami（Bristol-Myers Squibb K.K.）
SS3Multiple Myeloma 2020:
Management of the Newly Diagnosed Transplant Eligible Patient
Speaker: Jonathan L. KaufmanChair: Hideo Harigae
（Janssen Pharmaceutical K.K.）
SS4Statistical analyses of stem cell transplantation data using EZR (Easy R)
Speaker: Yoshinobu KandaChair: Satoshi Takahashi
（Fuji Pharma Co., Ltd.）
SS5New treatment strategy for myelofibrosis
Speaker: Shinsuke Takagi Masahiro TakeuchiChair: Nobuyuki Aotsuka
（Novartis Pharma K.K.）
SS6Key points for the introduction of the BCL-2 inhibitor VenclextaSpeaker: Tomoki Ito Noriko YokotaChair: Takanori Teshima
Ayako Mori（AbbVie GK）
SS7Overcoming challenges of refractory AML
-Current situations and the future prospect including FLT3 inhibitors-
Speaker: Naoyuki UchidaChair: Kouichi Akashi
（Astellas Pharma Inc.）
SS8Intravenous Access to Hematopoietic
Stem Cell Transplantation -Usefulness of PICC
Speaker: Yasuyuki AraiChair: Yoshinobu Maeda（Nippon Becton Dickinson
Company,Ltd.）
SS9Current status and future perspective
of conditioning regimen for allogeneic stem cell transplantationSpeaker: Hisashi YamamotoChair: Masashi Sawa
（Otsuka Pharmaceutical Co.,LTD.）
SS10Management and follow-up after hematopoietic stem cell transplantation
Speaker: Ryoji Kobayashi Hideki AraokaChair: Sakiko Kondo
（Novartis Pharma K.K.）
LS2Daratumumab treatment for multiple myeloma
Speaker: Kazutaka SunamiChair: Tatsuo Ichinohe
（Janssen Pharmaceutical K.K.）
LS3Practice of relapsed/refractory acute lymphoblastic leukemia treatment in our hospital
Speaker: Noriko DokiChair: Yosuke Minami（Pfizer Japan Inc.）
LS4Brand new strategy for
IFI management in evolving hematology malignancy treatment approach
Speaker: Toshihiro MiyamotoChair: Takanori Teshima（MSD K.K.）
LS5MSC for GVHD
Speaker: Jun Kato Motohiro KatoChair: Koichi Miyamura
（JCR Pharmaceuticals Co., Ltd.）
LS6New aspects of antifungal
management after hematopoietic stem cell transplantationSpeaker: Yuki MoriChair: Makoto Murata（Sumitomo Dainippon Pharma Co., Ltd.）
LS7Novel therapeutic strategy
for relapsed/refractory AML
Speaker: Takahiro YamauchiChair: Yasushi Miyazaki
（DAIICHI SANKYO COMPANY, LIMITED）
LS8Factors predicting
outcome after allogeneic HSCT for myelofibrosisSpeaker: Yasuharu Hamano
Chair: Shingo Yano（MOCHIDA PHARMACEUTICAL CO.,LTD）
LS9Management of cytomegalovirus infection in the Reiwa era.
-Choosing wisely-Speaker: Yoshinobu KandaChair: Takehiko Mori
（Mitsubishi Tanabe Pharma Corporation）
LS10Update on treatment and diagnosis of GVHDSpeaker: Yoshihiro InamotoChair: Yoshinobu Maeda（Novartis Pharma K.K.）
LS11Optimizing stem cell mobilization
in the era of plerixaforSpeaker: Nobuhiro TsukadaChair: Masahiro Kizaki（Sanofi K.K.）
Bruch up onLTFU NurseSayaka HonmaHitomi Nishimoto
P-001～P-009 Stem Cell Mobilization and CollectionP-011～P-015 Transplant SourceP-017～P-023 ConditioningP-025～P-047 Transplant ImmunityP-049～P-053 Immunotherapy/Cell TherapyP-055 Child-specific Transplant DiseaseP-057～P-099 Transplant OutcomesP-101～P-117 Malignant Lymphoma/ATLP-119～P-133 Minimal Residual Disease and RecurrenceP-135～P-145 Early ComplicationP-147～P-183 Late ComplicationP-185～P-193 Bacterial InfectionP-195～P-213 Viral InfectionP-215～P-227 Fungal Infection/Other InfectionP-229～P-231 LTFU/QOLP-233～P-235 Marrow Donor Program/Cord Blood Bank/DonorsP-237 Hematopoietic Cell Transplant Coordinator and CoordinateP-239～P-249 Management/Care/Team Medical-careP-251～P-267 RehabilitationP-269～P-275 TDM/Drugs
Poster Presentation
NurseP1-01～P1-12 CareNurseP1-13～P1-14 Infection controlNurseP1-15～P1-22 Follow-upNurseP1-23～P1-27 Decision supportNurseP1-28 Team approachNurseP1-29～P1-32 Nursing Management, Education
Nursing Poster Presentation
Posterremoval
E
P.7 P.7 P.8 P.8 P.8 P.8 P.9 P.9
P.21 P.23
P.37 P.38
P.41 P.42
P.45 P.46
P.30
P.34
P.25
P.29
P.33
P.26
P.24
P.31 P.32
P.39 P.40
P.43 P.44
P.48
P.27 P.28
P.35
P.47
P.36
P.4 P.4P.80
P.81 P.10
P.3 P.4
P.5
P.9
P.6 P.7P.6
P.3
P.83
P.5
DAY 2 Friday, March 6, 202021:3020:0019:0018:0017:0016:0015:0014:0013:0012:0011:0010:009:008:007:30
Glass Building
Hall EHall Building
Tokyo International Forum
Room14FHall C
Room27F
Hall B7（1）
Room37F
Hall B7（2）
Room45F
Hall B5
Room57F
Hall D7
Room65F
Hall D5
Room71F
Hall D1
Room85FG502
Room95FG510
Room104FG402
Room114FG409
Room126FG602
PosterB2F
ExhibitionB2F
: English EL : Educational LectureLS : Luncheon Seminar SS : Sweets SeminarE
17:15～18:008:30～10:00
9:00～18:00
10:00～17:15
9:00～10:00 10:10～11:10
9:00～10:00 10:10～11:10
9:00～10:00 10:10～11:10
9:00～10:00 10:10～11:10
10:10～10:58
10:20～11:08
9:00～10:00
9:00～9:48
9:00～10:12
10:10～11:22
13:25～14:37
13:30～14:30 14:40～15:40
13:30～14:30 14:40～15:40
13:30～14:30 14:40～15:28
14:50～15:50
13:30～14:42 14:50～16:02
13:30～14:42
13:30～14:42
9:00～10:00 13:45～14:4510:10～11:10
13:50～14:30 14:40～15:55
14:40～15:55
Reception19:30～21:30
9:00～11:00 13:45～15:15
9:00～10:30
9:00～10:30
13:30～14:40 14:45～16:0010:40～11:10
18:30～13:00～13:45
11:30～12:20 16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
16:10～17:00
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
11:30～12:20
12:35～13:00
9:00～9:30 9:35～10:05 10:10～10:40 10:45～11:15 13:30～14:00 14:05～14:35 14:40～15:10 15:15～15:45
MiniConcert
14:55～15:55
18:00～18:30
14:50～16:02
Oral Session 1Transplant Source 1Yasuyuki Arai
Oral Session 2Transplant Source 2Yoshihiro Inamoto
Oral Session 16Viral Infection 1Takanobu Morishita
Oral Session 17Viral Infection 2Akihiro Yokoyama
Oral Session 20LTFU/QOLYasuyuki Inoue
Oral Session 21ImmunizationSatoshi Iyama
Oral Session 24Rehabilitation 1
Eisei Kondo
Oral Session 25Rehabilitation 2Hiroya Tamaki
Oral Session 9GVHD/GVL 2Kazutaka Ozeki
Oral Session 13Early Complication(Engraftment Failure)Satoshi Nishiwaki
Oral Session 4Conditioning 1Naomi Kawashima
Oral Session 8GVHD/GVL 1Hiroaki Shimizu
Oral Session 12Early Complication(TMA/SOS)Takahiko Nakane
Oral Session 5Conditioning 2Shigeru Kusumoto
Oral Session 3Transplant Source 3
Ayako Arai
Oral Session 10GVHD/GVL 3Tomomi Toubai
Oral Session 11GVHD/GVL 4Tatsunori Goto
Oral Session 18Immunotherapy/Cell Therapy 1Kazuhiko Ikeda
Oral Session 19Immunotherapy/Cell Therapy 2Shinichi Kako
Oral Session 22Nutrition
Management 1Shigeo Fuji
Oral Session 23Nutrition
Management 2Sachiko Seo
Oral Session 27Histocompatibility
AntigenIlseung Choi
Oral Session 6Immune ReconstitutionShingo Kurahashi
Oral Session 7TDM/DrugsTakuro Nishikawa
Oral Session 14Early Complication(Pretransplant Evaluation/Others)Hisayuki Yokoyama
Oral Session 26Management/Care/Team Medical-care
Taku Kikuchi
Oral Session 15Early Complication(Heart/Lungs/Central Nervous System)Kentaro Fukushima
Oral Sessionfor Nurse 1
Transplant NursingYumiko Kiso Yuko Shimizu
Oral Sessionfor Nurse 2LTFU/QOLKazuyo YoshikawaRei Yamaoka
The allied organizations forumfor promoting hematopoieticstem cell transplantation
【Live Video】The forum of allied organizationspromoting hematopoietic stemcell transplantation (HSCT)
Symposium 1Recent advances in genomicsand genome-engineering inHematology/OncologyKoichi Akashi, Seishi Ogawa
SpecialPlanning 1Minoko TakahashiShuichi Taniguchi
Nursing EducationalLecture 1
Speaker: Yuka OzasaChair: Kazue Mori
Nursing EducationalLecture 2
Speaker: Sanae TakanashiChair: Megumi Fujisawa
OpeningCeremony
EL1Speaker: Nobuhiro TsukadaChair: Chiaki Nakaseko
EL2Speaker: Tomohiro MorioChair: Yoshiyuki Takahashi
EL3Speaker: Hiroki YamaguchiChair: Fumihiko Ishikawa
EL4Speaker: Gou YamamotoChair: Koji Idutsu
EL5Speaker: Atsushi KikutaChair: Takahiro Fukuda
EL6Speaker: Atsushi ManabeChair: Masami Inoue
EL7Speaker: Hiroshi KimuraChair: Kimikazu Matsumoto
EL8Speaker: Takahiro MaedaChair: Seishi Ogawa
PosterPresentationPoster mounting Poster viewing
Exhibition
E
E
E
Symposium 2Cord Blood Transplantation
in Future Satoshi Takahashi, Shuichi Taniguchi
Current Seminar 1Koji NagafujiTakahiro Fukuda
HCTC WorkshopShinichiro Mori, Yuka Nagai
Workshop 1Yuichiro NawaYoshikiyo Ito
Workshop 2Takehiko MoriYoshihiko Soga
CurrentSeminar 2Akihiro Shimosaka
E
LS1The importance of oral supportive care for
hematopoietic stem cell transplantation recipients - to fulfill our responsibility for life
Speaker: Yoshihiko SogaChair: Maki Yokota
（Chugai Pharmaceutical Co., Ltd）
SS1High-dose chemotherapy in pediatric malignant solid tumorSpeaker: Fuminori Iwasaki Maki Taduke
Chair: Masami Inoue Tomoko Fukuchi
（Sumitomo Dainippon Pharma Co., Ltd.）
SS2Pathophysiology and immune-targeted therapeutic approach of multiple myeloma in 2020Speaker: Junya KurodaChair: Kazutaka Sunami（Bristol-Myers Squibb K.K.）
SS3Multiple Myeloma 2020:
Management of the Newly Diagnosed Transplant Eligible Patient
Speaker: Jonathan L. KaufmanChair: Hideo Harigae
（Janssen Pharmaceutical K.K.）
SS4Statistical analyses of stem cell transplantation data using EZR (Easy R)
Speaker: Yoshinobu KandaChair: Satoshi Takahashi
（Fuji Pharma Co., Ltd.）
SS5New treatment strategy for myelofibrosis
Speaker: Shinsuke Takagi Masahiro TakeuchiChair: Nobuyuki Aotsuka
（Novartis Pharma K.K.）
SS6Key points for the introduction of the BCL-2 inhibitor VenclextaSpeaker: Tomoki Ito Noriko YokotaChair: Takanori Teshima
Ayako Mori（AbbVie GK）
SS7Overcoming challenges of refractory AML
-Current situations and the future prospect including FLT3 inhibitors-
Speaker: Naoyuki UchidaChair: Kouichi Akashi
（Astellas Pharma Inc.）
SS8Intravenous Access to Hematopoietic
Stem Cell Transplantation -Usefulness of PICC
Speaker: Yasuyuki AraiChair: Yoshinobu Maeda（Nippon Becton Dickinson
Company,Ltd.）
SS9Current status and future perspective
of conditioning regimen for allogeneic stem cell transplantationSpeaker: Hisashi YamamotoChair: Masashi Sawa
（Otsuka Pharmaceutical Co.,LTD.）
SS10Management and follow-up after hematopoietic stem cell transplantation
Speaker: Ryoji Kobayashi Hideki AraokaChair: Sakiko Kondo
（Novartis Pharma K.K.）
LS2Daratumumab treatment for multiple myeloma
Speaker: Kazutaka SunamiChair: Tatsuo Ichinohe
（Janssen Pharmaceutical K.K.）
LS3Practice of relapsed/refractory acute lymphoblastic leukemia treatment in our hospital
Speaker: Noriko DokiChair: Yosuke Minami（Pfizer Japan Inc.）
LS4Brand new strategy for
IFI management in evolving hematology malignancy treatment approach
Speaker: Toshihiro MiyamotoChair: Takanori Teshima（MSD K.K.）
LS5MSC for GVHD
Speaker: Jun Kato Motohiro KatoChair: Koichi Miyamura
（JCR Pharmaceuticals Co., Ltd.）
LS6New aspects of antifungal
management after hematopoietic stem cell transplantationSpeaker: Yuki MoriChair: Makoto Murata（Sumitomo Dainippon Pharma Co., Ltd.）
LS7Novel therapeutic strategy
for relapsed/refractory AML
Speaker: Takahiro YamauchiChair: Yasushi Miyazaki
（DAIICHI SANKYO COMPANY, LIMITED）
LS8Factors predicting
outcome after allogeneic HSCT for myelofibrosisSpeaker: Yasuharu Hamano
Chair: Shingo Yano（MOCHIDA PHARMACEUTICAL CO.,LTD）
LS9Management of cytomegalovirus infection in the Reiwa era.
-Choosing wisely-Speaker: Yoshinobu KandaChair: Takehiko Mori
（Mitsubishi Tanabe Pharma Corporation）
LS10Update on treatment and diagnosis of GVHDSpeaker: Yoshihiro InamotoChair: Yoshinobu Maeda（Novartis Pharma K.K.）
LS11Optimizing stem cell mobilization
in the era of plerixaforSpeaker: Nobuhiro TsukadaChair: Masahiro Kizaki（Sanofi K.K.）
Bruch up onLTFU NurseSayaka HonmaHitomi Nishimoto
P-001～P-009 Stem Cell Mobilization and CollectionP-011～P-015 Transplant SourceP-017～P-023 ConditioningP-025～P-047 Transplant ImmunityP-049～P-053 Immunotherapy/Cell TherapyP-055 Child-specific Transplant DiseaseP-057～P-099 Transplant OutcomesP-101～P-117 Malignant Lymphoma/ATLP-119～P-133 Minimal Residual Disease and RecurrenceP-135～P-145 Early ComplicationP-147～P-183 Late ComplicationP-185～P-193 Bacterial InfectionP-195～P-213 Viral InfectionP-215～P-227 Fungal Infection/Other InfectionP-229～P-231 LTFU/QOLP-233～P-235 Marrow Donor Program/Cord Blood Bank/DonorsP-237 Hematopoietic Cell Transplant Coordinator and CoordinateP-239～P-249 Management/Care/Team Medical-careP-251～P-267 RehabilitationP-269～P-275 TDM/Drugs
Poster Presentation
NurseP1-01～P1-12 CareNurseP1-13～P1-14 Infection controlNurseP1-15～P1-22 Follow-upNurseP1-23～P1-27 Decision supportNurseP1-28 Team approachNurseP1-29～P1-32 Nursing Management, Education
Nursing Poster Presentation
Posterremoval
E
P.7 P.7 P.8 P.8 P.8 P.8 P.9 P.9
P.21 P.23
P.37 P.38
P.41 P.42
P.45 P.46
P.30
P.34
P.25
P.29
P.33
P.26
P.24
P.31 P.32
P.39 P.40
P.43 P.44
P.48
P.27 P.28
P.35
P.47
P.36
P.4 P.4P.80
P.81 P.10
P.3 P.4
P.5
P.9
P.6 P.7P.6
P.3
P.83
P.5
